Wellington Management Group LLP Verona Pharma PLC Transaction History

Wellington Management Group LLP

$545 Billion
Q3 2025

A detailed history of Wellington Management Group LLP transactions in Verona Pharma PLC stock. As of the latest transaction made, Wellington Management Group LLP holds 18,632 shares of VRNA stock, worth $1.99 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,632

Previous 1,629,848 98.86%

Holding current value

$1.99 Million

Previous $154 Million 98.71%

% of portfolio

0.0%

Previous 0.03%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$90.08 - $106.69 $145 Million - $172 Million	-1,611,216 Reduced 98.86%	18,632 $1.99 Million
Q2 2025 Aug 14, 2025	SELL	$53.9 - $98.68 $27 Million - $49.5 Million	-501,654 Reduced 23.54%	1,629,848 $154 Million
Q1 2025 May 13, 2025	BUY	$44.81 - $69.63 $95.5 Million - $148 Million	2,131,502 New	2,131,502 $135 Million
Q4 2024 Feb 12, 2025	BUY	$28.71 - $47.02 $32.9 Million - $53.9 Million	1,146,609 Added 61.03%	3,025,241 $140 Million
Q3 2024 Nov 14, 2024	BUY	$15.46 - $30.16 $4.75 Million - $9.27 Million	307,272 Added 19.55%	1,878,632 $54 Million

Q2 2024 Aug 13, 2024	SELL	$11.48 - $17.02 $26.8 Million - $39.8 Million	-2,338,106 Reduced 59.81%	1,571,360 $22.7 Million
Q1 2024 May 15, 2024	BUY	$15.3 - $20.24 $59.8 Million - $79.1 Million	3,909,466 New	3,909,466 $62.9 Million
Q4 2023 Feb 12, 2024	BUY	$11.94 - $20.47 $45.2 Million - $77.5 Million	3,783,994 New	3,783,994 $75.2 Million
Q3 2023 Nov 14, 2023	BUY	$16.3 - $22.09 $2.68 Million - $3.63 Million	164,268 Added 3.82%	4,467,571 $72.8 Million
Q2 2023 Aug 14, 2023	BUY	$19.41 - $23.43 $19.6 Million - $23.7 Million	1,011,830 Added 30.74%	4,303,303 $91 Million
Q1 2023 May 12, 2023	SELL	$18.06 - $25.27 $991,439 - $1.39 Million	-54,897 Reduced 1.64%	3,291,473 $66.1 Million
Q4 2022 Feb 13, 2023	SELL	$9.84 - $26.13 $8.18 Million - $21.7 Million	-830,906 Reduced 19.89%	3,346,370 $87.4 Million
Q3 2022 Nov 14, 2022	BUY	$4.14 - $13.59 $1.45 Million - $4.74 Million	349,127 Added 9.12%	4,177,276 $42.7 Million
Q2 2022 Aug 15, 2022	BUY	$3.55 - $5.06 $175,242 - $249,781	49,364 Added 1.31%	3,828,149 $16 Million
Q1 2022 May 16, 2022	SELL	$4.82 - $6.98 $5.08 Million - $7.35 Million	-1,053,203 Reduced 21.8%	3,778,785 $18.9 Million
Q4 2021 Feb 11, 2022	BUY	$3.91 - $7.08 $2.1 Million - $3.81 Million	537,950 Added 12.53%	4,831,988 $32.5 Million
Q3 2021 Nov 15, 2021	BUY	$5.29 - $6.35 $2.02 Million - $2.43 Million	382,198 Added 9.77%	4,294,038 $23.5 Million
Q2 2021 Aug 16, 2021	BUY	$5.72 - $9.09 $650,358 - $1.03 Million	113,699 Added 2.99%	3,911,840 $25.6 Million
Q1 2021 May 17, 2021	BUY	$7.08 - $9.33 $18.1 Million - $23.8 Million	2,552,442 Added 204.9%	3,798,141 $31.8 Million
Q4 2020 Feb 12, 2021	BUY	$5.51 - $8.11 $6.86 Million - $10.1 Million	1,245,699 New	1,245,699 $8.72 Million

Others Institutions Holding VRNA

# of Institutions

273

Shares Held

76.9M

Call Options Held

686K

Put Options Held

442K

View Full List

About Verona Pharma plc

Ticker VRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,954,200
Market Cap $6.52B
Description
Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...

More about VRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Verona Pharma PLC Transaction History